Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three inorganic compounds—sodium fluoride, potassium oxalate, and strontium chloride—used primarily in dental care products for the management of dentin hypersensitivity. Each component acts via a distinct mechanism: - Sodium fluoride strengthens tooth enamel and increases resistance to acid attack by promoting remineralization. - Potassium oxalate occludes dentinal tubules, reducing fluid movement within the tubules that can trigger nerve pain. - Strontium chloride also occludes dentinal tubules and may reduce nerve excitability, though it is generally considered less effective than potassium-based agents. The combination aims to provide both immediate and long-term relief from tooth sensitivity by blocking pain transmission (potassium), physically sealing exposed dentin (oxalate/strontium), and enhancing enamel strength (fluoride). These ingredients are commonly found in desensitizing toothpaste or topical dental treatments for patients with sensitive teeth[4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium fluoride + potassium oxalate + strontium chloride.